Aditya Birla Sun Life Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8569 Cr | ₹840 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 10 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.82 | 2.27 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | 3.45% | 4.45% |
6 Month | 12.02% | 8.91% |
1 Year | 10.9% | 8.21% |
3 Year | 24.95% | 23.39% |
5 Year | 21.24% | 18.89% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | 7.77% | 7.46% |
1 Year | 12.61% | 9.57% |
3 Year | 25.2% | 24.17% |
5 Year | 20.43% | 18.87% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 17.67% | 27.28% |
3 Year | 20.32% | 16.45% |
5 Year | 20.52% | 23.91% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 14.75% | 15.80% |
Sharp | 1.20% | 1.02% |
Beta | 0.90% | 0.96% |
Alpha | 0.72% | -2.02% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Funds Managed | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 0.53 | 1.58 |
Large Cap | 35.06 | 28.37 |
Mid Cap | 31.99 | 44.79 |
Small Cap | 32.41 | 25.26 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 0.53 | 1.58 |
Healthcare | 99.47 | 97.5 |
Basic Materials | - | 0.92 |
Top Comparisons
Invesco India Financial Services Fund - Retail Growth
3Y Returns22.47%
UTI Banking and Financial Services Fund - Regular Plan - Growth Option
3Y Returns17.54%
Mahindra Manulife ELSS Tax Saver Fund- Regular Plan - Growth
3Y Returns15.44%
HSBC ELSS Tax saver Fund - Regular Growth
3Y Returns21.06%
Invesco India Equity Savings Fund - Regular Plan - Growth
3Y Returns11.52%
Invesco India Equity Savings Fund - Regular Plan - Growth
3Y Returns11.52%
HDFC Manufacturing Fund - Regular (G)
3Y Returns0%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Regular Plan - Growth
3Y Returns22.12%